Navigation Links
Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
Date:10/23/2007

ooking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the Company's expectations related to the U.K. combination REOLYSIN(R)/cyclophosphamide clinical trial, and the Company's belief as to the potential of REOLYSIN(R) as a cancer therapeutic, involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the efficacy of REOLYSIN(R) as a cancer treatment, the tolerability of REOLYSIN(R) outside a controlled test, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize REOLYSIN(R), uncertainties related to the research and development of pharmaceuticals and uncertainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statements.


'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. The state of global biotech: An Ernst & Young perspective
2. Olympics of biotechnology has international flavor
3. Biotech officials praise focus of new venture fund
4. Getting noticed in Genetown: Wisconsin biotech on display
5. Madison biotech NimbleGen files for IPO; one of states best-funded firms
6. Wisconsin biotech firm receives $107K NIH grant
7. Biotech executive books a career flight thats closer to home
8. Manufacturing partnership will move into biotech and biomedical spaces
9. Wisconsin wont get Georgia biotech without a fight
10. The 10 biggest events shaping biotech in 2006
11. Gala Biotech among companies sold for $3.3 billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/11/2010)... at Philadelphia Conference , ... Chicago, ... of Clinical Trial Operations (CTO) software, today announced it will ... Bank and Cowen & Company at CBI,s 2010 Accounting and ... attended each year by over 300 finance, accounting, audit and ...
(Date:3/10/2010)... March 11 Thomson Reuters today announced it has ... Times Higher Education,s influential World University Rankings. The survey reflects ... resource to the global scholarly community. , ... ... ...
(Date:3/10/2010)... today announced the appointment of Mr. Kevin Giese , President, CEO and Director of BioMS Medical and Mr. Laine Woollard, QC , Senior Legal ... ... , ... ... ...
(Date:3/10/2010)... , ... ... ... , ... ...
Breaking Biology Technology:ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress 2ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress 3Thomson Reuters Launches Academic Reputation Survey as Part of Global Institutional Profiles Project 2Thomson Reuters Launches Academic Reputation Survey as Part of Global Institutional Profiles Project 3Spectral appoints two new board members 2Spectral appoints two new board members 3BR Ventures Invests in Semprae Laboratories 2BR Ventures Invests in Semprae Laboratories 3BR Ventures Invests in Semprae Laboratories 4
... Inc.,(Nasdaq: ONTY ) (TSX: ONY) (the "Company") ... in a Phase 1b clinical trial of PX-12 ... proprietary small molecule,inhibitor of thioredoxin, a protein that ... survival and drug resistance of,many cancers., The ...
... lecture and present a poster on proprietary siRNA ... targeting ... Quark Pharmaceuticals, Inc., a,development-stage pharmaceutical company discovering and developing ... the Cambridge Healthcare Institute,s 9th Annual Beyond,Genome Conference on ...
... DURECT Corporation,(Nasdaq: DRRX ) announced today that ... has been submitted to the U.S. Food,and Drug ... long,acting oral formulation of oxycodone intended to treat ... Remoxy is designed to resist,common methods of prescription ...
Other Biology Technology:Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer 2Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer 3Quark Pharmaceuticals to Participate in 9th Annual Beyond Genome Conference 2Quark Pharmaceuticals to Participate in 9th Annual Beyond Genome Conference 3New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 2New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 3New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 4New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 5
(Date:3/10/2010)... may eventually emerge as a lymphoma treatment, according to ... International Conference on Advances in Cancer Research: From the ... , Lymphoma is a cancer of the immune system ... are then further classified into B-cell and T-cell groups. ... resistant to standard treatment and thus new therapies are ...
(Date:3/10/2010)... Ala. Discovery of an antibiotic,s capacity to ... movement disorder researchers with leads to more desirable ... of Alabama scientists co-authoring a paper publishing March ... Mechanisms ., "It,s our hope that this ... clinical trial to evaluate the potential of drugs ...
(Date:3/10/2010)... Scientists have gained new insight into why a relatively ... hearing deficits, long after hearing is restored to normal. ... 11 issue of the journal Neuron , reveals ... auditory cortex is quite vulnerable if it does not ... , It is well established that degraded sensory experience ...
Breaking Biology News(10 mins):Movement disorder symptoms are lessened by an antibiotic 2Movement disorder symptoms are lessened by an antibiotic 3Research reveals that temporary hearing deprivation can lead to 'lazy ear' 2Mastery of Myeloma Continuing Education Training Program for the Multidisciplinary Care Team Set for Western Region 59508 1Mastery of Myeloma Continuing Education Training Program for the Multidisciplinary Care Team Set for Western Region 59508 2ATS Medical Products Featured Prominently at European Association for Cardio Thoracic Surgeons 28EACTS 29 Annual Meeting 5497 1ATS Medical Products Featured Prominently at European Association for Cardio Thoracic Surgeons 28EACTS 29 Annual Meeting 5497 2ATS Medical Products Featured Prominently at European Association for Cardio Thoracic Surgeons 28EACTS 29 Annual Meeting 5497 3ATS Medical Products Featured Prominently at European Association for Cardio Thoracic Surgeons 28EACTS 29 Annual Meeting 5497 4Healthcare Reform Activist Dr Lee Vliet Speaks Out on Healthcare Reform 59505 1Healthcare Reform Activist Dr Lee Vliet Speaks Out on Healthcare Reform 59505 2
... major cause of hospital-acquired infections can persist for ... in healthcare settings, including bed linens, computer keyboard ... today at the 105th General Meeting of the ... (MRSA) is a major cause of hospital-acquired infections ...
... of two critical proteins that normally shut down during ... the Cold Spring Harbor Laboratory have cured fruit flies ... same proteins-known in short form as CREB and HSP-70--exist ... study results, published online today by the Proceedings of ...
... University of Pittsburgh researchers first to report function of ... each other by an extensive network of tiny tunnels ... used to shoot signals to distant cells. This surprising ... of Medicine researchers in the September issue of the ...
Other Biology News:Huntington's cure in flies lays groundwork for broader treatment approaches 2'Underground' tunnels discovered as means for communication between immune system cells 2'Underground' tunnels discovered as means for communication between immune system cells 3'Underground' tunnels discovered as means for communication between immune system cells 4